BeOne Medicines (ONC) Other Gross PP&E Adjustments (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Gross PP&E Adjustments data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Other Gross PP&E Adjustments rose 156.73% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 156.73% YoY) and the FY2025 annual result came in at $1.7 billion, up 250.89% from the prior year.
• Other Gross PP&E Adjustments grew to $1.8 billion in Q1 2026 per ONC's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Other Gross PP&E Adjustments topped out at $1.8 billion in Q1 2026 and bottomed at -$29.8 million in Q4 2023.
• The 5-year median for Other Gross PP&E Adjustments is $336.3 million (2022), against an average of $589.2 million.
• The widest annual swing landed in 2024, when Other Gross PP&E Adjustments slumped 116.73%; it then soared 4545.86% in 2025.
• Tracing ONC's Other Gross PP&E Adjustments over 5 years: stood at $300.5 million in 2022, then plunged by 109.9% to -$29.8 million in 2023, then surged by 1752.62% to $491.8 million in 2024, then jumped by 250.89% to $1.7 billion in 2025, then rose by 3.63% to $1.8 billion in 2026.
• Per Business Quant, the three latest ONC Other Gross PP&E Adjustments figures stand at $1.8 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.7 billion (Q3 2025).

Peer Comparison